CS255045B1 - N-(2,6-dichlorophenyl)-benziminophenylether - Google Patents

N-(2,6-dichlorophenyl)-benziminophenylether Download PDF

Info

Publication number
CS255045B1
CS255045B1 CS866327A CS632786A CS255045B1 CS 255045 B1 CS255045 B1 CS 255045B1 CS 866327 A CS866327 A CS 866327A CS 632786 A CS632786 A CS 632786A CS 255045 B1 CS255045 B1 CS 255045B1
Authority
CS
Czechoslovakia
Prior art keywords
dichlorophenyl
ether
benziminophenyl
benziminophenylether
reaction mixture
Prior art date
Application number
CS866327A
Other languages
Czech (cs)
Other versions
CS632786A1 (en
Inventor
Rudolf Smrz
Jiri Strof
Vaclav Zoula
Lubos Dejmek
Original Assignee
Rudolf Smrz
Jiri Strof
Vaclav Zoula
Lubos Dejmek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rudolf Smrz, Jiri Strof, Vaclav Zoula, Lubos Dejmek filed Critical Rudolf Smrz
Priority to CS866327A priority Critical patent/CS255045B1/en
Publication of CS632786A1 publication Critical patent/CS632786A1/en
Publication of CS255045B1 publication Critical patent/CS255045B1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Řešení se týká N-(2,6-dichlorfenyl)- -benziminofenyletheru, který slouží jako meziprodukt pro přípravu sodné soli diclofenaou, která je žádaným léčivem s protibolestivým a protizánětlivým účinkem.The solution relates to N- (2,6-dichlorophenyl) - -benziminophenyl ether, which serves as a an intermediate for the preparation of the sodium salt of diclofenene, which is the desired anti-pain drug and anti-inflammatory effect.

Description

který je meziproduktem přípravy o-(2,6-dichloranilino)-fenyloctové kyseliny, jejíž sodné sůl (diclofenac natrium) je rozšířeným léčivem s protibolestivým a protizánětlivým účinkem.which is an intermediate for the preparation of o- (2,6-dichloroanilino) -phenylacetic acid, whose sodium salt (diclofenac sodium) is a widespread drug with an anti-pain and anti-inflammatory effect.

Nová sloučenina vzorce I se připravuje reakcí N-(2,6-dichlorfenyl)-benzimidoylchloridu s fenolétem alkalického kovu v prostředí protofilního rozpouštědla (alifatické ethery nebo estery alifatických kyselin), v rozmezí teplot 10°až 90°Cj zředěním reakční směsi vodou, separací organické fáze a odpařením rozpouštědla se získá surový N-(2,6-dichlorfenyl)-benziminofenylether jako žlutý viskózni, stáním krystalující olej. Krystalizací surového produktu z petroletheru se získá čistý N-(2,6-dichlorfenyl)-benziminofenylether, čistoty 99 %-ní (stanoveno plynovou chromatografií), ve formě žluté krystalické látky t.t. 7O,5°až 71,0°C.The novel compound of formula (I) is prepared by reacting N- (2,6-dichlorophenyl) -benzimidoyl chloride with an alkali metal phenolate in a protophilic solvent medium (aliphatic ethers or esters of aliphatic acids), between 10 ° and 90 ° C by diluting the reaction mixture with water, separating the organic phase and evaporation of the solvent gave crude N- (2,6-dichlorophenyl) -benziminophenyl ether as a yellow viscous, crystalline oil on standing. Crystallization of the crude product from petroleum ether gave pure N- (2,6-dichlorophenyl) -benziminophenyl ether, purity 99% (determined by gas chromatography), as a yellow crystalline solid, m.p. 70.5 ° to 71.0 ° C.

Následující příklad přípravy sloučeniny podle vynálezu látku pouze dokládá ale neomezuje.The following example illustrates the preparation of a compound of the invention but does not limit it.

PříkladExample

K suspensi 13,3 g (0,10 molu) fenolétu draselného ve 20 ml me255 045 thanolu se za stálého míchání a chlazení vodní lázní přidá roztok 28,5 g 0,10 molu N-(2,6-diehlorfenyí)-benzimidoylchloridu v 30 ml octanu ethylnatého tak, aby teplota reakční směsi byla udržována v rozmezí 30 až 40 C; po odeznění exothermní reakce se míchaná reakční směs vyhřeje na 50°C a udržováním této teploty po dobu 3 hod. se dosáhne proreagovéní obou komponent. Reakční směs, ochlazené na laboratorní teplotu, se zředí 70 ml octanu ethylnatého a protřepéním dest. vodou (β x 30 ml) se odstání anorganické soli a zbytky nezreagovaného fenolátu draselného; organická fáze, vysušená síranem sodným, se zbaví rozpouštědla destilací za sníženého tlaku. Získá se 25,0 g tj. 73,0 % th. olejovítého produktu, který stáním postupně zkrystaluje. Krystalizací z hexanu se získá 20 g N(2,6-dichlorfenyl)-benziminofenyletheru čistoty 98,5 %-ní jako žluté krystalické látky t.t. 7O,5°až 71°C.To a suspension of 13.3 g (0.10 mole) of potassium phenoleate in 20 ml of me255 045 thanol is added, while stirring and cooling in a water bath, a solution of 28.5 g of 0.10 mole of N- (2,6-dichlorophenyl) benzimidoyl chloride in 30 ml of ethyl acetate such that the temperature of the reaction mixture is maintained between 30 and 40 ° C; after the exothermic reaction subsided, the stirred reaction mixture was heated to 50 ° C and maintained at this temperature for 3 hours to produce a pro-reaction of both components. The reaction mixture, cooled to room temperature, was diluted with 70 ml of ethyl acetate and shaken with dest. water (β x 30 ml) leaves inorganic salts and unreacted potassium phenolate residues; the organic phase, dried over sodium sulfate, is freed from the solvent by distillation under reduced pressure. 25.0 g, i.e. 73.0% of th, is obtained. an oily product which gradually crystallizes on standing. Crystallization from hexane gave 20 g of N (2,6-dichlorophenyl) -benziminophenyl ether of purity 98.5% as a yellow crystalline solid, m.p. 70.5 ° -71 ° C.

Claims (1)

PŘEDMĚT VYNÁLEZUSUBJECT OF THE INVENTION 1. N-(2,6-dichlorfenyl)-benziminofenylether vzorce IA N- (2,6-dichlorophenyl) -benziminophenyl ether of formula I IAND Vytiskly Moravské tiskařské závody, střed. 11 100, tř.Lidových milicí 3, OlomoucPrinted by Moravian printing works, center. 11 100, the class of People's Militia 3, Olomouc Cena: 2,40 KčsPrice: 2,40 Kčs
CS866327A 1986-09-01 1986-09-01 N-(2,6-dichlorophenyl)-benziminophenylether CS255045B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS866327A CS255045B1 (en) 1986-09-01 1986-09-01 N-(2,6-dichlorophenyl)-benziminophenylether

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS866327A CS255045B1 (en) 1986-09-01 1986-09-01 N-(2,6-dichlorophenyl)-benziminophenylether

Publications (2)

Publication Number Publication Date
CS632786A1 CS632786A1 (en) 1987-06-11
CS255045B1 true CS255045B1 (en) 1988-02-15

Family

ID=5410054

Family Applications (1)

Application Number Title Priority Date Filing Date
CS866327A CS255045B1 (en) 1986-09-01 1986-09-01 N-(2,6-dichlorophenyl)-benziminophenylether

Country Status (1)

Country Link
CS (1) CS255045B1 (en)

Also Published As

Publication number Publication date
CS632786A1 (en) 1987-06-11

Similar Documents

Publication Publication Date Title
US4147702A (en) 1,4-Dioxane polycarboxylates
US5334747A (en) Method of preparing substituted malonic ester anilides and malonic acid mono-anilides
SE452610B (en) SETTING DIVERSE RACEMIC CIS-1,2-CYCLOPROPANDICARBOXYLIC ACID DERIVATIVES
EP0052200A1 (en) Cyclic acetals of N-acylated glutamic acid gamma-semialdehydes, process for their preparation and their use
US5872261A (en) Preparation of sulfo-N- hydroxy succinimide salts with intermediate formation of diester
US4772711A (en) Method for the preparation of 3-aminoacrylic acid esters
CS255045B1 (en) N-(2,6-dichlorophenyl)-benziminophenylether
US6160171A (en) Trifluoro-substituted benzoic acid, esters thereof, and process for producing the same
US4348332A (en) Phosphonoformaldehyde, a process for its preparation and its use as an intermediate product for the preparation of medicaments
US5177247A (en) Process for the preparation of hydroxyphenylpropionates
SU472506A3 (en) Method for producing morpholine derivatives
SU1754712A1 (en) N-(3-nitro-4-chlorophenylsulfonyl)-anthranilic acid as an intermediate for synthesis of n-(4-chlorophenyl)-2-[(3-nitro- 4-chlorophenylsulfonyl)-amino]-5-bromobenzamide, showing antitrichocephaliasis activity
JP4138067B2 (en) Method for producing methine derivative
US4709075A (en) Preparation of alkyl N-maleylphenylalanate
US5908955A (en) Process for producing alkyl 3-amino-4-substituted benzoates
US4172208A (en) 5-Bromo-5,5-dicarboxyethylvalaraldehyde diethyl acetal
US4377531A (en) Method for the alkylation of phenylacetonitriles
JPS61286346A (en) Production of 2,2-bis(4'-acryloyloxy-3',5'-dibromophenyl) propane
US5530159A (en) Preparation of α-alaninediacetic acid or its alkali metal or ammonium salts
US4331606A (en) N-(Substituted chromone-3-carbonyl)-phenylglycine derivatives
JPH1036326A (en) Acid adduct salt of 3-ethynylaniline compound and purification of 3-ethynylaniline compound
RU1794941C (en) N-(3-nitro-4-chlorophenylsulfonyl)-5-chloroanthranilic acid as an intermediate for synthesis of n-(4-chlorophenyl)-2-(3-nitro-4-chlorophenylsulfonyl)amino-5- chlorobenzamide showing antitrichocephaliasis activity
SU526285A3 (en) The method of obtaining derivatives of 3-and / or 2-butenoic acid
HU199855B (en) Process for producing n-sulfonyl-square brackets open n-(phosphonomethyl)-glycyl square brackets closed-amine derivatives
SU528874A3 (en) Method for preparing 4.2 benzoxazepine derivatives